Related Experiment Video

Updated: Jun 1, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Lipoprotein abnormalities in patients with atherosclerotic renovascular disease

Elzbieta Nowakowska Fortuna1, Hans Herlitz, Aso Saeed

  • 1Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Sweden.

Kidney & Blood Pressure Research
|May 27, 2011
PubMed

Insights

Atherosclerotic renovascular disease patients exhibit elevated levels of specific lipoproteins, indicating an increased risk for cardiovascular events. These findings highlight potential targets for managing atherosclerosis in ARVD.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Renal Artery Disease

Background:

  • Atherosclerotic renovascular disease (ARVD) patients face a high risk of cardiovascular mortality.
  • Characterizing lipoprotein (Lp) subclasses is crucial for understanding ARVD pathophysiology.

Purpose of the Study:

  • To investigate apolipoprotein (Apo)-defined lipoprotein subclass abnormalities in ARVD patients.
  • To assess the impact of candesartan treatment on these lipoprotein profiles.

Main Methods:

  • Baseline measurements in 42 ARVD patients post-renal angioplasty, all on statins.
  • Comparison with 20 age-matched healthy controls.
  • Randomization to candesartan or non-renin-angiotensin-aldosterone system inhibitors for 11 months.

Main Results:

  • ARVD patients showed significantly elevated ApoC-III, LpB:C:E, and total ApoC-III-containing lipoproteins versus controls.
  • Plasma renin activity was independently associated with baseline ApoC-III levels.
  • Candesartan treatment did not resolve these lipoprotein abnormalities.

Conclusions:

  • Statin-treated ARVD patients present an atherogenic lipoprotein profile.
  • Elevated ApoC-III-containing, triglyceride-rich lipoproteins may accelerate atherosclerotic disease progression.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...